New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
04:55 EDTTHRX, THRX, NSPH, NSPHEuropean Society of Clinical Microbiology to hold a conference
24th European Congress of Clinical Microbiology and Infectious Diseases to be held in Barcelona, Spain on May 10-13.
News For THRX;NSPH From The Last 14 Days
Check below for free stories on THRX;NSPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 7, 2014
10:00 EDTNSPHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:16 EDTNSPHNanosphere downgraded at Craig-Hallum
Subscribe for More Information
08:09 EDTNSPHNanosphere downgraded to Hold from Buy at Craig-Hallum
Subscribe for More Information
August 6, 2014
18:54 EDTNSPHOn The Fly: After Hours Movers
Subscribe for More Information
16:33 EDTTHRXTheravance reports Q2 EPS (57c), consensus (44c)
Reports Q2 revenue $934K, may not compare to consensus $4.39M.
16:25 EDTNSPHNanosphere lowers 2014 revenue outlook to $14M from $19M-$21M
Nanosphere sees 2014 revenue $14M, consensus $19.31M, and 175 to 200 new customer placements; down from the previous guidance of $19M-$21M and approximately 200 new customer placements. The company said, "However, our instrument sales fell well short of expectations due to timing of hospital capital budgets and a continued lengthy customer implementation process; therefore, we are lowering guidance to reflect this pace of instrument sales and its associated impact on consumable and total revenue."
16:24 EDTNSPHNanosphere reports Q2 EPS (13c), consensus (12c)
Reports Q2 revenue $2.67M, consensus $3.9M. The company added 37 new Verigene System customer placements.
16:23 EDTTHRXTheravance names Michael Aguiar as president, CEO
Subscribe for More Information
16:00 EDTNSPHNanosphere trading halted, pending news
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use